BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8865524)

  • 1. Modulation of plasma fibrinogen levels by ticlopidine in healthy volunteers and patients with stable angina pectoris.
    de Maat MP; Arnold AE; van Buuren S; Wilson JH; Kluft C
    Thromb Haemost; 1996 Aug; 76(2):166-70. PubMed ID: 8865524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of ticlopidine on platelet function at rest and after exercise in patients with previous myocardial infarct. An acute crossover double-blind study].
    Tullio D; Valerio A; Ottaviano MA; Di Guglielmo L; Accettura P; Caraceni CE; Sclocco T
    Minerva Med; 1990; 81(1-2):87-92. PubMed ID: 2179769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of ticlopidine of platelet function in men with stable angina pectoris.
    Berglund U; von Schenck H; Wallentin L
    Thromb Haemost; 1985 Dec; 54(4):808-12. PubMed ID: 3911481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variation in estrogen receptor, C-reactive protein and fibrinogen does not predict the plasma levels of inflammation markers after longterm hormone replacement therapy.
    de Maat MP; Madsen JS; Langdahl B; Bladbjerg EM; Tofteng CL; Abrahamsen B; Rejnmark L; Brixen K; Christensen K; Jespersen J; Kristensen SR
    Thromb Haemost; 2007 Feb; 97(2):234-9. PubMed ID: 17264952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clopidogrel inhibits platelet aggregation in patients on aspirin with stable chronic angina pectoris.
    Saha S; Berglund M; Sylvén C; Gordon A; Agewall S
    Int J Cardiol; 2008 Jan; 123(2):195-6. PubMed ID: 17320208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of C-reactive protein, fibrinogen and antithrombin-III as risk factors for coronary artery disease.
    Cavusoglu Y; Gorenek B; Alpsoy S; Unalir A; Ata N; Timuralp B
    Isr Med Assoc J; 2001 Jan; 3(1):13-6. PubMed ID: 11344793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of plasma fibrinogen levels by ciprofibrate and gemfibrozil in primary hyperlipidaemia.
    de Maat MP; Knipscheer HC; Kastelein JJ; Kluft C
    Thromb Haemost; 1997 Jan; 77(1):75-9. PubMed ID: 9031453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decrease of fibrinogen in patients with peripheral atherosclerotic disease by ticlopidine.
    Randi ML; Mares M; Fabris F; Tison T; Barbone E; Girolami A
    Arzneimittelforschung; 1991 Apr; 41(4):414-6. PubMed ID: 1859515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clopidogrel pretreatment abolishes increase of PAI-1 after coronary stent implantation.
    Katsaros KM; Kastl SP; Huber K; Zorn G; Maurer G; Glogar D; Wojta J; Christ G; Speidl WS
    Thromb Res; 2008; 123(1):79-84. PubMed ID: 18558425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of aspirin plus clopidogrel on inflammatory markers in patients with non-ST-segment elevation acute coronary syndrome.
    Chen YG; Xu F; Zhang Y; Ji QS; Sun Y; Lü RJ; Li RJ
    Chin Med J (Engl); 2006 Jan; 119(1):32-6. PubMed ID: 16454979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-inflammatory effects of clopidogrel intake in renal transplant patients: effects on platelet-leukocyte interactions, platelet CD40 ligand expression, and proinflammatory biomarkers.
    Graff J; Harder S; Wahl O; Scheuermann EH; Gossmann J
    Clin Pharmacol Ther; 2005 Nov; 78(5):468-76. PubMed ID: 16321613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased C-reactive protein level after coronary stent implantation in patients with stable coronary artery disease.
    Almagor M; Keren A; Banai S
    Am Heart J; 2003 Feb; 145(2):248-53. PubMed ID: 12595841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized comparison of the effects of ASA plus clopidogrel versus ASA alone on early platelet activation in acute coronary syndromes with elevated high-sensitivity C-reactive protein and soluble CD40 ligand levels.
    Vavuranakis M; Latsios G; Aggelis D; Bosinakou I; Karambelas I; Tousoulis D; Toutouzas K; Stefanadis C
    Clin Ther; 2006 Jun; 28(6):860-71. PubMed ID: 16860169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of clopidogrel on soluble CD40 ligand and on high-sensitivity C-reactive protein in patients with stable coronary artery disease.
    Azar RR; Kassab R; Zoghbi A; Aboujaoudé S; El-Osta H; Ghorra P; Germanos M; Salamé E
    Am Heart J; 2006 Feb; 151(2):521.e1-521.e4. PubMed ID: 16442924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-Reactive protein and coronary artery disease: additional evidence of the implication of an inflammatory process in acute coronary syndromes.
    Abdelmouttaleb I; Danchin N; Ilardo C; Aimone-Gastin I; Angioï M; Lozniewski A; Loubinoux J; Le Faou A; Guéant JL
    Am Heart J; 1999 Feb; 137(2):346-51. PubMed ID: 9924170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-reactive protein levels are influenced by common IL-1 gene variations.
    Berger P; McConnell JP; Nunn M; Kornman KS; Sorrell J; Stephenson K; Duff GW
    Cytokine; 2002 Feb; 17(4):171-4. PubMed ID: 11991668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of platelet and leukocyte functions in effort angina patients using high shear conditions in small-sized collagen bead columns.
    Inami N; Nomura S; Kimura Y; Yamada K; Nakamori H; Takahashi N; Fukuhara S; Iwasaka T
    Clin Appl Thromb Hemost; 2007 Oct; 13(4):428-31. PubMed ID: 17911196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The relationship between serum C-reactive protein levels and coronary artery disease in patients with stable angina pectoris and positive exercise stress test].
    Türkoğlu EI; Gürgün C; Zoghi M; Türkoğlu C
    Anadolu Kardiyol Derg; 2004 Sep; 4(3):199-202. PubMed ID: 15355818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of C-reactive protein and fibrinogen on cardiovascular prognosis in patients with stable angina pectoris: the AtheroGene study.
    Sinning JM; Bickel C; Messow CM; Schnabel R; Lubos E; Rupprecht HJ; Espinola-Klein C; Lackner KJ; Tiret L; Münzel T; Blankenberg S;
    Eur Heart J; 2006 Dec; 27(24):2962-8. PubMed ID: 17132649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of gemfibrozil and ciprofibrate on plasma levels of tissue-type plasminogen activator, plasminogen activator inhibitor-1 and fibrinogen in hyperlipidaemic patients.
    Kockx M; de Maat MP; Knipscheer HC; Kastelein JJ; Kluft C; Princen HM; Kooistra T
    Thromb Haemost; 1997 Oct; 78(4):1167-72. PubMed ID: 9364979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.